SmallRig Shines at 2025 NAB Show with Three Innovative Products
LAS VEGAS, April 15, 2025 /PRNewswire/ — SmallRig is proud to announce our participation in the 2025 NAB Show, a prestigious global platform for engaging with... Read more.
BCG X Launches AI Science Institute to Help Companies Accelerate Scientific Research from Innovation to Impact
New Institute Harnesses the Expertise of BCG X’s Data Scientists and Engineers to Accelerate Scientific Breakthroughs in Partnership with Universities, Industry... Read more.
IDA and AUDC Partner on HK-AU Stablecoin-Based Cross-Border Trade Initiative
HONG KONG, April 15, 2025 /PRNewswire/ — IDA, a Hong Kong-based fintech company, and AUDC Pty Ltd have announced a strategic collaboration to launch a Hong... Read more.
PayPal and TerraPay Partner to Expand Access to Cross-Border Payments across Middle East and Africa
DUBAI, UAE, April 15, 2025 /PRNewswire/ — PayPal, a global digital payments and commerce platform, today announced a strategic partnership with TerraPay, a... Read more.
DuRoBo Debuts First Product: Krono–Your ePaper Focus Hub
NEW YORK, April 14, 2025 /PRNewswire/ — DuRoBo, a Dutch technology company, has introduced its debut product, Krono—an AI-powered ePaper focus hub. This... Read more.
Navigating Robotics Deployment Challenges with SINBON
With expertise in designing and manufacturing the nervous systems of robotics solutions, SINBON focuses on solving implementation challenges with customization.... Read more.
RLWRLD Raises $15M to Build ‘GPT for Robots,’ Backed by Asia’s Industrial Giants
As Silicon Valley builds AI for the internet, RLWRLD trains AI to act in the real world—with support from LG, SK, KDDI, ANA, and more SEOUL, South Korea and TOKYO,... Read more.
JelloX Biotech Establishes US Research Base
To further advance oncology with technology, the biotech startup is setting up a 3D cancer pathology lab in the Phoenix-based Discovery Oasis biotech space. PHOENIX,... Read more.
U.S. FDA grants interchangeable designation to YUFLYMA® (adalimumab-aaty), Celltrion’s biosimilar to Humira® (adalimumab)
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar, that is now interchangeable Interchangeable... Read more.
Whirlpool Corporation Declares Quarterly Dividend
BENTON HARBOR, Mich., April 14, 2025 /PRNewswire/ — Today, the board of directors of Whirlpool Corporation (the “Company”) declared a quarterly... Read more.